Login
Related Links
Breaking Gene Therapy News
Breaking gene therapy news items collected via Google News. Current news results for 'gene therapy' are sorted by date. Login and view all archived news items.
- Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment - Investing.com
Wed, 15 Jan 2025 01:43:4 GMT - Spark Therapeutics co-founder back at the helm of a Philadelphia gene therapy company - The Business Journals
Tue, 14 Jan 2025 21:00:0 GMT - Fresh off AbbVie update, Regenxbio inks $810M MPS gene therapy deal - FirstWord Pharma
Tue, 14 Jan 2025 16:22:1 GMT - RhyGaze raises $86 million to develop vision restoration gene therapy - Healio
Tue, 14 Jan 2025 15:42:2 GMT - Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI™ (eladocagene exuparvovec-tneq) - PR Newswire
Tue, 14 Jan 2025 15:00:0 GMT - FDA gives go-ahead for clinical testing of FA gene therapy SGT-212 - Friedreich's Ataxia News
Tue, 14 Jan 2025 14:51:2 GMT - The Impact of Targeted Gene Therapy and Nadofaragene Firadenovec on BCG-Unresponsive NMIBC - Urology Times
Tue, 14 Jan 2025 14:18:5 GMT - First participants randomized in AskBio Phase II gene therapy trial for Parkinson's disease - The Manila Times
Tue, 14 Jan 2025 14:15:5 GMT - Integrating CRISPR and biomaterials engineering for safer gene therapy - Health Tech World
Tue, 14 Jan 2025 13:23:3 GMT - Long-term potential revealed for novel modifier gene therapy - Marketscreener.com
Tue, 14 Jan 2025 13:01:3 GMT - Long-term potential revealed for novel modifier gene therapy - European Pharmaceutical Review
Tue, 14 Jan 2025 12:57:3 GMT - Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 2 - The Medicine Maker
Tue, 14 Jan 2025 12:49:5 GMT - RegenXBio sells Hunter syndrome gene therapy's U.S., Asia commercial rights for $110M upfront - Fierce Biotech
Tue, 14 Jan 2025 11:56:2 GMT - REGENXBIO Lands $810M Gene Therapy Deal with Nippon Shinyaku for Rare Disease Treatments - StockTitan
Tue, 14 Jan 2025 11:00:0 GMT - Research reveals inaccuracies in common gene therapy measurement technique - News-Medical.Net
Tue, 14 Jan 2025 04:09:0 GMT - 4D Molecular Therapeutics' SWOT analysis: gene therapy stock faces pivotal year - Investing.com
Tue, 14 Jan 2025 01:17:2 GMT - Durham biotech startup raises $175 million as it starts novel gene therapy trial - Raleigh News & Observer
Tue, 14 Jan 2025 00:08:0 GMT - JPM25: Deals, Summit’s bravado and gene therapy headwinds - BioPharma Dive
Mon, 13 Jan 2025 23:36:3 GMT - Tenaya Therapeutics Advances Gene Therapy Programs with Promising TN-201 Trial Progress - StockTitan
Mon, 13 Jan 2025 15:16:0 GMT - FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND - Inside Precision Medicine
Mon, 13 Jan 2025 15:00:2 GMT - AbbVie and REGENXBIO Advance Revolutionary One-Time Gene Therapy for Vision Loss Treatment - StockTitan
Mon, 13 Jan 2025 14:31:0 GMT - Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy - Business Wire
Mon, 13 Jan 2025 14:00:0 GMT - Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa - Ocugen
Mon, 13 Jan 2025 13:21:0 GMT - Verve Therapeutics Advances Heart Disease Gene Therapy Pipeline, Extends Cash Runway to 2027 - StockTitan
Mon, 13 Jan 2025 13:00:0 GMT - Ocugen's Gene Therapy Shows 100% Success Rate in 2-Year Vision Loss Treatment Trial - StockTitan
Mon, 13 Jan 2025 12:30:0 GMT - First in vivo CAR gene therapy trial in Europe approved - European Biotechnology News
Mon, 13 Jan 2025 09:44:0 GMT - Hope for the Haslams: UNM offered $6 million gene therapy treatment to two young Rio Rancho brothers - Rio Rancho Observer
Sun, 12 Jan 2025 18:00:0 GMT - Standardized Measurements Needed for AAVs in Gene Therapy, Study Finds - AJMC.com Managed Markets Network
Sun, 12 Jan 2025 14:02:5 GMT - 4DMT tosses 2 programs, halts funds for 3 others as it zeroes in on latest-stage clinical gene therapy - Fierce Biotech
Fri, 10 Jan 2025 20:00:0 GMT - Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration - Business Wire
Fri, 10 Jan 2025 14:00:0 GMT